Literature DB >> 30137251

Trends in Treatment Uptake and Provider Specialty for Hepatitis C Virus (HCV) Infection in the Veterans Affairs Healthcare System: Results From the Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES).

Adeel A Butt1,2, Peng Yan1, Vincent Lo Re Iii3, Obaid S Shaikh1, David B Ross4.   

Abstract

Between 2001 and 2017, 108133 persons (45.7% of diagnosed cases) were initiated on anti-hepatitis C virus treatment in the Veterans Affairs healthcare system. In 2017, nonphysician clinicians accounted for 22.2% of prescriptions, infectious diseases specialists for 14.9%, and gastroenterologists/hepatologists for 10.3%. In the pre-direct-acting antiviral era, they accounted for 7.2%, 26.7%, and 11.6%, respectively.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  DAA; ERCHIVES; HCV treatment cascade; HCV treatment uptake

Mesh：

Substances：

Year:  2019        PMID： 30137251     DOI： 10.1093/cid/ciy697

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  5 in total

1.  Hepatitis C Virus Treatment: Simplifying the Simple and Optimizing the Difficult.

Authors:  Oluwaseun Falade-Nwulia; Mark S Sulkowski
Journal:  J Infect Dis       Date:  2020-11-27       Impact factor: 5.226

2.  The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders.

Authors:  Xinyi Jiang; Hyun Jin Song; Wei Wang; Linda Henry; Lindsey M Childs-Kean; Vincent Lo Re; Haesuk Park
Journal:  J Manag Care Spec Pharm       Date:  2021-07

3.  Effectiveness of implementing a decentralized delivery of hepatitis C virus treatment with direct-acting antivirals: A systematic review with meta-analysis.

Authors:  Rodolfo Castro; Hugo Perazzo; Letícia Artilles Mello Mendonça de Araujo; Isabella Gonçalves Gutierres; Beatriz Grinsztejn; Valdiléa G Veloso
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

4.  Hepatitis C Care Continuum in a Human Immunodeficiency Virus (HIV) Positive Cohort: Data From the HIV Atlanta Veterans Affairs Cohort Study.

Authors:  Ruth O Adekunle; Kathryn DeSilva; Emily J Cartwright
Journal:  Open Forum Infect Dis       Date:  2020-03-12       Impact factor: 3.835

5.  Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure.

Authors:  Philip R Spradling; Yuna Zhong; Anne C Moorman; Loralee B Rupp; Mei Lu; Stuart C Gordon; Eyasu H Teshale; Mark A Schmidt; Yihe G Daida; Joseph A Boscarino
Journal:  Hepatol Commun       Date:  2020-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.